Demetrix, Inc. and UC Berkeley enter exclusive licensing agreement for cannabinoid production

Monday, March 4, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Demetrix obtains exclusive use of key intellectual property enabling the cost-effective production of cannabinoids using fermentation.

Demetrix, Inc. Logo



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store